Related Experiment Video
Updated: Mar 8, 2026

Development and Validation of a Methodology for Establishing Obese Rat Models with Typical Fatty Pancreas
Published on: November 11, 2025
Acanthosis Nigricans as a Clinical Predictor of Insulin Resistance in Obese Children
Young Kwon Koh1, Jae Hee Lee1, Eun Young Kim1
1Department of Pediatrics, Chosun University School of Medicine, Gwangju, Korea.
Insights
Acanthosis nigricans (AN) severity predicts insulin resistance in obese children. Severe AN (score ≥3) indicates a higher risk, with insulin resistance worsening as AN severity increases.
Area of Science:
- Pediatric Endocrinology
- Metabolic Syndrome Research
- Dermatology
Background:
- Obesity in children is a growing concern, often linked to metabolic complications.
- Insulin resistance is a key metabolic abnormality associated with childhood obesity.
- Acanthosis nigricans (AN) is a skin condition sometimes indicative of underlying metabolic issues.
Purpose of the Study:
- To assess the effectiveness of acanthosis nigricans (AN) severity as a predictor of insulin resistance in obese pediatric patients.
- To determine the correlation between AN severity and the degree of insulin resistance.
Main Methods:
- A cohort of 74 obese children was studied.
- Clinical measurements included BMI, waist circumference, and blood pressure.
- Fasting glucose, insulin, lipid profiles, liver enzymes, and uric acid were analyzed.
- Homeostatic model assessment for insulin resistance (HOMA-IR) and quantitative insulin sensitivity check index (QUICKI) were calculated.
- Receiver operating characteristic (ROC) curves evaluated the predictive utility of the AN score.
Main Results:
- Children with AN exhibited significantly higher fasting insulin levels and HOMA-IR scores compared to those without AN.
- An AN score of 3 or more demonstrated 56.8% sensitivity and 83.9% specificity for predicting insulin resistance.
- HOMA-IR scores progressively increased with AN severity: No AN, Mild AN, and Severe AN.
Conclusions:
- The severity of acanthosis nigricans correlates with the degree of insulin resistance in obese children.
- A severe AN score (≥3) identifies pediatric patients at elevated risk for insulin resistance.
- AN severity serves as a valuable clinical index for predicting insulin resistance in this population.
Purpose:
This study aimed to evaluate the utility of acanthosis nigricans (AN) severity as an index for predicting insulin resistance in obese children.
Methods:
The subjects comprised 74 obese pediatric patients who attended the Department of Pediatrics at Chosun University Hospital between January 2013 and March 2016. Waist circumference; body mass index; blood pressure; fasting glucose and fasting insulin levels; lipid profile; aspartate transaminase, alanine transaminase, glycated hemoglobin, C-peptide, and uric acid levels; and homeostatic model assessment insulin resistance (HOMA-IR) and quantitative insulin check sensitivity index (QUICKI) scores were compared between subjects with AN and those without AN. Receiver operating characteristic curves were used to investigate the utility of the AN score in predicting insulin resistance. HOMA-IR and QUICKI were compared according to AN severity.
Results:
The With AN group had higher fasting insulin levels (24.1±21.0 mU/L vs. 9.8±3.6 mU/L, p<0.001) and HOMA-IR score (5.74±4.71 vs. 2.14±0.86, p<0.001) than the Without AN group. The AN score used to predict insulin resistance was 3 points or more (sensitivity 56.8%, specificity 83.9%). HOMA-IR scores increased with AN severity, from the Without AN group (mean, 2.15; 95% confidence interval [CI], 1.72-2.57) to the Mild AN (mean, 4.15; 95% CI, 3.04-5.25) and Severe AN groups (mean, 7.22; 95% CI, 5.08-9.35; p<0.001).
Conclusion:
Insulin resistance worsens with increasing AN severity, and patients with Severe AN (AN score ≥3) are at increased risk of insulin resistance.
Related Concept Videos
Obesity
Diabetes: Symptoms, Diagnosis, and Complications
Diabetes Mellitus: Overview and Type I Subtype
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Diabetes Mellitus: Type 2 and Gestational

